Analysis | Samples | Factors | Units |
---|---|---|---|
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Acyl_carnitines_Sample_5_BIG | Treatment:BIG | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Acyl_carnitines_Sample_6_BIG | Treatment:BIG | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Acyl_carnitines_Sample_7_BIG | Treatment:BIG | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Acyl_carnitines_Sample_8_BIG | Treatment:BIG | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Lipids_Sample_5_BIG | Treatment:BIG | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Lipids_Sample_6_BIG | Treatment:BIG | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Lipids_Sample_7_BIG | Treatment:BIG | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Lipids_Sample_8_BIG | Treatment:BIG | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Acyl_carnitines_Sample_2_HB | Treatment:HB | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Acyl_carnitines_Sample_4_HB | Treatment:HB | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Lipids_Sample_2_HB | Treatment:HB | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Lipids_Sample_4_HB | Treatment:HB | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Acyl_carnitines_Sample_1_HB101 | Treatment:HB101 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Acyl_carnitines_Sample_2_HB101 | Treatment:HB101 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Acyl_carnitines_Sample_3_HB101 | Treatment:HB101 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Lipids_Sample_1_HB101 | Treatment:HB101 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Lipids_Sample_2_HB101 | Treatment:HB101 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Lipids_Sample_3_HB101 | Treatment:HB101 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Acyl_carnitines_Sample_1_HBS | Treatment:HBS | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Acyl_carnitines_Sample_3_HBS | Treatment:HBS | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Lipids_Sample_1_HBS | Treatment:HBS | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190326_BJJ_Lipids_Sample_3_HBS | Treatment:HBS | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Acyl_carnitines_Sample_4_PA14 | Treatment:PA14 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Acyl_carnitines_Sample_5_PA14 | Treatment:PA14 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Acyl_carnitines_Sample_6_PA14 | Treatment:PA14 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Lipids_Sample_4_PA14 | Treatment:PA14 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Lipids_Sample_5_PA14 | Treatment:PA14 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Lipids_Sample_6_PA14 | Treatment:PA14 | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Acyl_carnitines_Sample_7_P.LUMIN | Treatment:P.Lumin | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Acyl_carnitines_Sample_8_P.LUMIN | Treatment:P.Lumin | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Acyl_carnitines_Sample_9_P.LUMIN | Treatment:P.Lumin | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Lipids_Sample_7_P.lumin | Treatment:P.Lumin | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Lipids_Sample_8_P.lumin | Treatment:P.Lumin | Peak area ratio |
Reversed phase UNSPECIFIED ION MODE | 20190510_BJJ_Lipids_Sample_9_P.lumin | Treatment:P.Lumin | Peak area ratio |